JD Health will sign contracts with more than 20 global pharmaceutical and health brands at the CIIE, including Pfizer, Merck, and Novo
It has signed contracts with more than 20 global pharmaceutical and health brands such as Pfizer and Merck, and officially launched one-stop medical services in China for overseas patients.
Quick Look
- The 9th China International Import Expo opened in Shanghai.
- JD Health signed contracts with more than 20 global pharmaceutical and health brands at the event, and officially launched a one-stop "come to China for medical treatment" business for overseas patients, accelerating the entry of global good drugs into China and the export of Chinese medical services overseas.
AI-generated summary
Why It Matters
The 9th China International Import Expo opened in Shanghai, with major multinational pharmaceutical companies deepening cooperation with China's local health platform.
On November 5, the 9th China International Import Expo opened in Shanghai. According to Cao Dong, member of the SEC of JD Group and CEO of JD Health, JD Health will sign contracts with more than 20 global pharmaceutical and health brands during the CIIE, including Pfizer, Merck, Novo, Centrum Calcium, Jianmeisheng, Omron, Siemens, etc., covering the fields of medicine, nutritional health, medical equipment and other fields. At present, JD Health has in-depth cooperation with the world's top 50 multinational pharmaceutical companies. At this CIIE, JD Health also launched a medical service in China, providing international patients with one-stop service for medical treatment in China.
As of the first three quarters of 2026, JD Health has launched more than 100 new drugs online, exceeding the total of last year.
Buy global good medicines on JD.com, cooperation is not just about putting them on the shelves
At this CIIE, JD Health’s cooperation with pharmaceutical companies extends from new product launches and new product underwriting to patient management and AI innovation. Many pharmaceutical companies have cooperated with JD Health for more than 10 years, and this year's CIIE will continue to expand on the basis of the original cooperation.
Judging from the progress since 2026, the cooperation between multinational pharmaceutical companies and JD Health is deepening. In terms of launch speed, Novartis Remibrutinib tablets were launched on the entire network in March, Pfizer Xinweiying® was launched on the entire JD Health network in April, Leopard® was launched on the entire network in August... Takeda Ozawayue® was exclusively launched on the entire network on October 15. After the initial release, patients can go to JD Internet Hospital for online follow-up consultation, prescription renewal, and drug purchase.
On November 5, JD Health made its debut at the CIIE and joined hands with Pfizer to launch the "White Paper on Metabolic Health of Chinese Women" project
In terms of cooperation results, Boehringer Ingelheim's sales of related products on JD Health increased by nearly 20% year-on-year from January to September 2026; Helion's tenth anniversary of cooperation, in 2025, the transaction volume of related products on JD channels increased by more than 20% year-on-year. 50%, accumulatively reaching more than 5 million people with pain; the turnover of Ogallon's self-operated channels increased by 42% year-on-year; as of September 30, the sales of AstraZeneca's related products in JD's self-operated channels increased by 51.1% year-on-year.
Pharmaceutical companies are interested in JD Health’s omni-channel supply chain, Internet medical services and compliance capabilities, as well as its full-scenario AI implementation capabilities.
As of the first three quarters of 2026, JD Health has launched more than 100 new drugs online, exceeding the total of last year, covering fields such as tumors, skin, chronic diseases, GLP-1 weight loss metabolism, and women's health. JD Health’s judgment on “first launch” is: the first launch is not a press conference, but a fulfillment order. After the press conference and hot searches, whether the medicine can be prescribed, obtained at the pharmacy, and picked up during follow-up is the real second half of the first game. Buying global good medicines on JD.com means that these global good medicines can enter China as soon as possible and be used by patients in need as soon as possible.
Coming to China for medical treatment: Good medicines from around the world come to China, and China’s good medical services serve the world.
During the CIIE, JD Health officially launched the "Come to China for Medical Treatment" business to provide overseas patients with one-stop service for medical treatment in China. It is reported that JoyDoctor’s domestic iOS version, overseas iOS version and overseas Google version have all been launched, and there are already service cases in categories such as physical examination, dentistry, rare diseases, and dermatology pre-surgery outpatient clinics. The first batch focuses on serving countries such as Qatar, the United Arab Emirates, Kazakhstan, and Indonesia, covering the Middle East, Central Asia, Southeast Asia, Mongolia and other regions.
It is understood that overseas patients are not familiar with Chinese hospital procedures. When they come to China for medical treatment, they help patients connect with hospitals and doctors, arrange appointments and itineraries, and assist with visas. When they arrive in China, they are accompanied by translators and diagnosis and treatment coordination, and they also have follow-up follow-up after returning home. The cooperative hospitals cover many top medical institutions in Beijing, Shanghai, Guangzhou and other places, as well as self-operated institutions such as JD Physical Examination, Traditional Chinese Medicine Orthopedics, JD Medical Aesthetics and other self-operated institutions, and undertake healthy travel and medical services, with a contract fulfillment network all over the country.
The country has made it clear to expand inbound health consumption and build an international medical tourism brand. JD Health’s medical services in China are in line with this policy direction. JD Health stated that this is an attempt to open up China's high-quality medical and health service capabilities to the world. The current focus is to serve the already implemented categories well, and cooperative hospitals and self-operated institutions will gradually access them according to their service capabilities.
"The world's first launch is in China, and China's first launch is on JD.com. It's not just a shout out. It's about new drugs being released one after another so that patients in need can use them and use them well." A person in charge of JD Health said that in addition to the accelerating entry of global good medicines, good nutrition, and good equipment into China, China's good hospitals, good doctors, and good services are also serving patients around the world, allowing people in need to find suitable medical resources faster.
What to Watch
AI outlook — possibilities, not facts
JD Health will gradually connect more cooperative hospitals and self-operated institutions to provide medical services in China.
Very likely · Within months
Open Questions
- What is the specific service pricing system for medical treatment in China?
- What is the actual conversion scale of the first batch of overseas patients?



